These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 39177576)
21. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway. Liu T; Liu Y; Bao X; Tian J; Liu Y; Yang X PLoS One; 2013; 8(9):e75864. PubMed ID: 24086649 [TBL] [Abstract][Full Text] [Related]
22. Could trop-2 overexpression indicate tumor aggressiveness among prostatic adenocarcinomas? Akarken İ; Dere Y Ann Diagn Pathol; 2021 Feb; 50():151680. PubMed ID: 33341704 [TBL] [Abstract][Full Text] [Related]
23. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. Nodin B; Johannesson H; Wangefjord S; O'Connor DP; Lindquist KE; Uhlén M; Jirström K; Eberhard J Diagn Pathol; 2012 Aug; 7():115. PubMed ID: 22935204 [TBL] [Abstract][Full Text] [Related]
24. Clinical Impact of Mismatch Repair Protein Testing on Outcome of Early Staged Colorectal Carcinomas. Gandhi JS; Goswami M; Sharma A; Tanwar P; Gupta G; Gupta N; Pasricha S; Mehta A; Singh S; Agarwal M; Gupta N J Gastrointest Cancer; 2018 Dec; 49(4):406-414. PubMed ID: 28585041 [TBL] [Abstract][Full Text] [Related]
25. TROP2 Expression and Therapeutic Implications in Cutaneous Squamous Cell Carcinoma: Insights From Immunohistochemical and Functional Analysis. Tanegashima K; Tanaka Y; Ito T; Oda Y; Nakahara T Exp Dermatol; 2024 Oct; 33(10):e15196. PubMed ID: 39422290 [TBL] [Abstract][Full Text] [Related]
26. RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas. Deb S; Xu H; Tuynman J; George J; Yan Y; Li J; Ward RL; Mortensen N; Hawkins NJ; McKay MJ; Ramsay RG; Fox SB Br J Cancer; 2014 Mar; 110(6):1606-13. PubMed ID: 24548858 [TBL] [Abstract][Full Text] [Related]
27. TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells. Li Z; Jiang X; Zhang W Biochem Biophys Res Commun; 2016 Jan; 470(1):197-204. PubMed ID: 26773504 [TBL] [Abstract][Full Text] [Related]
28. Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts. Bahlinger V; Branz A; Strissel PL; Strick R; Lange F; Geppert CI; Klümper N; Hölzel M; Wach S; Taubert H; Sikic D; Wullich B; Angeloni M; Ferrazzi F; Diehl L; Kovalenko M; Elboudwarej E; Jürgensmeier JM; Hartmann A; Eckstein M Histopathology; 2024 Apr; 84(5):863-876. PubMed ID: 38196202 [TBL] [Abstract][Full Text] [Related]
29. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT. Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z Oncotarget; 2017 Jul; 8(29):47052-47063. PubMed ID: 28423362 [TBL] [Abstract][Full Text] [Related]
30. Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1. Hsu EC; Rice MA; Bermudez A; Marques FJG; Aslan M; Liu S; Ghoochani A; Zhang CA; Chen YS; Zlitni A; Kumar S; Nolley R; Habte F; Shen M; Koul K; Peehl DM; Zoubeidi A; Gambhir SS; Kunder CA; Pitteri SJ; Brooks JD; Stoyanova T Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2032-2042. PubMed ID: 31932422 [TBL] [Abstract][Full Text] [Related]
31. Clinical significance of TROP2 expression in colorectal cancer. Ohmachi T; Tanaka F; Mimori K; Inoue H; Yanaga K; Mori M Clin Cancer Res; 2006 May; 12(10):3057-63. PubMed ID: 16707602 [TBL] [Abstract][Full Text] [Related]
32. Correlation between Trop2 and amphiregulin coexpression and overall survival in gastric cancer. Zhao W; Ding G; Wen J; Tang Q; Yong H; Zhu H; Zhang S; Qiu Z; Feng Z; Zhu J Cancer Med; 2017 May; 6(5):994-1001. PubMed ID: 28256068 [TBL] [Abstract][Full Text] [Related]
33. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer. Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727 [TBL] [Abstract][Full Text] [Related]
34. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma. Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202 [TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status. Lugli A; Zlobec I; Baker K; Minoo P; Tornillo L; Terracciano L; Jass JR J Clin Pathol; 2007 May; 60(5):534-9. PubMed ID: 16816167 [TBL] [Abstract][Full Text] [Related]
36. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway. Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125 [TBL] [Abstract][Full Text] [Related]
37. Trop2 Expression in Extramammary Paget's Disease and Normal Skin. Ito T; Tanegashima K; Tanaka Y; Hashimoto H; Murata M; Oda Y; Kaku-Ito Y Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299325 [TBL] [Abstract][Full Text] [Related]
38. Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors. Dum D; Taherpour N; Menz A; Höflmayer D; Völkel C; Hinsch A; Gorbokon N; Lennartz M; Hube-Magg C; Fraune C; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T; Luebke AM Pathobiology; 2022; 89(4):245-258. PubMed ID: 35477165 [TBL] [Abstract][Full Text] [Related]
39. Different effects of ERβ and TROP2 expression in Chinese patients with early-stage colon cancer. Fang YJ; Wang GQ; Lu ZH; Zhang L; Li JB; Wu XJ; Ding PR; Ou QJ; Zhang MF; Jiang W; Pan ZZ; Wan DS Tumour Biol; 2012 Dec; 33(6):2227-35. PubMed ID: 23055188 [TBL] [Abstract][Full Text] [Related]
40. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Cubas R; Zhang S; Li M; Chen C; Yao Q Mol Cancer; 2010 Sep; 9():253. PubMed ID: 20858281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]